Precision medicine tailors therapeutics to individual patients’ diseases, and is seen as the future of...
Up To Date
Backgrounds & Stories
After two years of unprecedented growth driven by the pandemic, investment attracted by Spanish biotech...
Depending on who you talk to, artificial intelligence (AI) is either a saviour or an enslaver. The concerns...
Myoglobin producer Paleo NV has closed a €12m Series A financing. The financing round was led by DSM...
Generic and biosimilar manufacturer Sandoz, (still) a subsidiary of Novartis, is planning a new biologics...
Sweden is set to introduce a new Biobank Act on July 1, 2023, replacing the current regulation. The new act...